<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6A4E1271-E1F8-4DA7-B77B-002849719D61"><gtr:id>6A4E1271-E1F8-4DA7-B77B-002849719D61</gtr:id><gtr:name>National Institute of Child Health (NICH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5F44D980-91F5-4741-B8D1-6E7FB9183303"><gtr:id>5F44D980-91F5-4741-B8D1-6E7FB9183303</gtr:id><gtr:name>Fudan University</gtr:name><gtr:address><gtr:line1>670 Guoshun Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7008F77D-D7F3-4558-AEE7-9195B7890A2D"><gtr:id>7008F77D-D7F3-4558-AEE7-9195B7890A2D</gtr:id><gtr:name>Moorfields Eye Hospital NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Ophthalmology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6A4E1271-E1F8-4DA7-B77B-002849719D61"><gtr:id>6A4E1271-E1F8-4DA7-B77B-002849719D61</gtr:id><gtr:name>National Institute of Child Health (NICH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5F44D980-91F5-4741-B8D1-6E7FB9183303"><gtr:id>5F44D980-91F5-4741-B8D1-6E7FB9183303</gtr:id><gtr:name>Fudan University</gtr:name><gtr:address><gtr:line1>670 Guoshun Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7008F77D-D7F3-4558-AEE7-9195B7890A2D"><gtr:id>7008F77D-D7F3-4558-AEE7-9195B7890A2D</gtr:id><gtr:name>Moorfields Eye Hospital NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/925F3641-B145-40D6-BE22-6E1DA17FD276"><gtr:id>925F3641-B145-40D6-BE22-6E1DA17FD276</gtr:id><gtr:firstName>Gloria</gtr:firstName><gtr:otherNames>Astrid</gtr:otherNames><gtr:surname>Limb</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK008722%2F1"><gtr:id>FCA1A660-2EF7-4BC2-B888-9F24B92A5896</gtr:id><gtr:title>Investigation of factors that prevent endogenous regeneration of the retina by M&amp;uuml;ller stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K008722/1</gtr:grantReference><gtr:abstractText>Adult human retina harbours a population of M&amp;uuml;ller cells with stem cell characteristics. Although these cells have the ability to grow and neurally differentiate in vitro, there is no evidence that they regenerate retina in vivo. It has been thought that factors released during reactive gliosis, a glial proliferation observed in all retinal degenerative conditions, are responsible for the inhibition of retinal regeneration by endogenous stem cells. The proposed research aims to identifiy factors that may promote neural regeneration of diseased retina by stimulating the endogenous proliferation and neural differentiation of M&amp;uuml;ller stem cells. Using proteomic approaches, we will investigate the total protein and cytokine expression profile of fragments of human gliotic retina, surgically removed as part of the treatment for complicated retinal detachment, and will compare this profile with that of normal cadaveric donor retina. Factors found to be selectively increased or decreased in degenerated retina will then be examined for their ability to inhibit or promote M&amp;uuml;ller stem cell growth and differentiation in vitro. Once candidate factors have been found to be active on the inhibition or promotion of these cell functions, we will confirm their roles by blocking or promoting their activities using agonist or antagonist molecules for these factors. The work will be undertaken in collaboration with Prof. Sun Xinghai and Dr Lei Yuan from the Eye Hospital at Fudan University, Shanghai. The proteomic analysis will be performed at the UCL Institute of Ophthalmology and is expected to identify candidate factors which can be examined by both the UK and the Fudan group on M&amp;uuml;ller stem cell growth and differentiation. The project will form part of a PhD training program for a Chinese student who will visit the UCL Institute of Ophthalmology for a year. Funding for her visit and that of Prof Sun and Dr Lei, her PhD supervisors, is being sought by the Fudan University group fthe Natural Science Foundation of China.</gtr:abstractText><gtr:technicalSummary>Degeneration of retinal neurons is the ultimate cause of blindness resulting from prevalent conditions, such as age related macular degeneration (AMD), diabetic retinopathy (DR), end stage glaucoma, retinal detachment and retinitis pigmentosa. Although extensive research is being undertaken to replace damaged retinal neurons by neural stem cell transplantation, stimulation of endogenous proliferation and neural differentiation of retinal stem cells would be a preferred alternative to the transplantation approaches currently being investigated. 
The research therefore aims to identify factors that may inhibit regeneration of diseased retina, and whose expression may be potentially altered to promote the endogenous proliferation and neural differentiation of M&amp;uuml;ller stem cells in situ. Using proteomic approaches, we will investigate the total protein and cytokine expression profile of fragments of human gliotic retina, surgically removed as part of the treatment for complicated retinal detachment, and will compare this profile with that of normal cadaveric retina. Factors selectively upregulated or downregulated in gliotic retina will be examined for their ability to inhibit or promote M&amp;uuml;ller stem cell growth and differentiation in vitro. 
Candidate factors found to be active on the inhibition or promotion of these cell functions, will be further examined for their ability to block or promote stem cell activities using agonist or antagonist molecules for these factors. The work will be undertaken in collaboration with Prof. Sun Xinghai and Dr Lei Yuan from the Eye Hospital at Fudan University, Shanghai. The proteomic analysis will be performed at the UCL Institute of Ophthalmology and is expected to identify candidate factors which can be examined by both the UK and the Fudan group on M&amp;uuml;ller stem cell growth and differentiation. The project will form part of a PhD training program for a Chinese student who will visit the UCL Institute of Ophthalmology for a year.</gtr:technicalSummary><gtr:potentialImpactText>The proposal has direct relevance to the exploration of stem cell based therapies for human application. The research aims to develop treatments for ocular conditions affecting a very large number of individuals worldwide. Degeneration of retinal neurons is the ultimate cause of blindness resulting from prevalent ocular diseases, such as age related macular degeneration (AMD), diabetic retinopathy (DR), end stage glaucoma, retinal detachment and retinitis pigmentosa, amongst others. According to Vision 2020 (www.vision2020.org), a global initiative for the prevention of blindness, AMD affects approximately 25 to 30 million people over the age of 55 worldwide, whilst glaucoma affects 60 million individuals worldwide. With recent advances in laser and surgical treatments, it is possible to prevent substantial visual loss in many patients, but in a long term, it is impossible to prevent blindness finally occurring in many individuals. The proposed research will be focused on the identification of factors that may inhibit neural regeneration of diseased retina, whose expression may be potentially altered to promote the endogenous proliferation and neural differentiation of M&amp;uuml;ller stem cells within the retina. Stimulation of endogenous proliferation and neural differentiation to replace damaged neurons would be a preferred alternative to the transplantation procedures currently being investigated. If this approach could be implemented -an injection of a given factor will be preferred to retinal transplantation surgery- it will avoid the trauma of surgical procedures and could potentially be performed with minimal resources.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>35678</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Child Health (NICH)</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:description>Proteomics assays</gtr:description><gtr:id>2661F282-B7C7-4646-B9E2-FE731DCFD1B2</gtr:id><gtr:impact>Paper in preparation for publication</gtr:impact><gtr:outcomeId>56d87e4f3f4621.21249668-1</gtr:outcomeId><gtr:partnerContribution>Provided equipment and knowledge of know how</gtr:partnerContribution><gtr:piContribution>We performed proteomics analyses of human and zebrafish retina</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fudan University</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Department of Ophthalmology</gtr:department><gtr:description>Endogenous retinal regeneration by stem cells</gtr:description><gtr:id>123921CA-80FF-402D-9FA5-67524A8E5EA4</gtr:id><gtr:impact>Poster presented at the meeting of the International Society for Ocular cell biology in Oxford, Sept 2013</gtr:impact><gtr:outcomeId>b7AmuVisSdh-1</gtr:outcomeId><gtr:partnerContribution>Testing candidate molecules for their potential to inhibit Muller stem cell growth and differentiation in vitro</gtr:partnerContribution><gtr:piContribution>Proteomic studies to identify candidate molecules that inhibit endogenous retina regeneration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Moorfields Eye Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sourcing human retina tissue</gtr:description><gtr:id>07C952C1-647C-40CE-83F5-4F08E1BB449C</gtr:id><gtr:impact>Paper publication</gtr:impact><gtr:outcomeId>56d87a88510e48.20570488-1</gtr:outcomeId><gtr:partnerContribution>Collaborator provided tissue from patients for research</gtr:partnerContribution><gtr:piContribution>Investigated the proteomic profile of gliotic tissue</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Moorfields Eye Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Moorfields Biomedical Research Centre</gtr:department><gtr:description>Proteomics in zebrafish retina</gtr:description><gtr:id>DE937E18-B0D9-465F-868C-E2EA1707805F</gtr:id><gtr:impact>A paper is in preparation</gtr:impact><gtr:outcomeId>56d87d47843065.65272465-1</gtr:outcomeId><gtr:partnerContribution>Provided methodology and analysis of tissue used for proteomics</gtr:partnerContribution><gtr:piContribution>Investigated proteomics profile in the zebrafish retina</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Meeting of the Scientific and Medical Advisory Board of Retina International</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>649630D3-41FF-47CB-8C7F-5C9C1F163D44</gtr:id><gtr:impact>Presentation generated important discussions with retina specialists

N/A</gtr:impact><gtr:outcomeId>545a6652367a00.48487546</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Eye Research conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5A7CE929-77A2-4EB2-9B62-1D83F56FCFD0</gtr:id><gtr:impact>Scientific presentation and discussions with other researchers</gtr:impact><gtr:outcomeId>58c6eb29af5261.73734149</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Worshop invitation</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0C0DA678-B900-496F-A452-FCB7ECE46A14</gtr:id><gtr:impact>Invitation to close workshop organized by the National Eye Institute of the United States in May 2016, as part of their Audacious Goal Initiative to cure blindness by 2020. The main purpose of the meeting was to discuss potential approaches for replacement of retinal ganglion cells from endogenous cell sources..</gtr:impact><gtr:outcomeId>58c6e875cbca58.61680136</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=U5pEcFPsOWU&amp;feature=youtu.be</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Eye Research conference (Poster presentation)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>968EB8B7-B048-47DA-A09B-D924BE46248B</gtr:id><gtr:impact>Poster presentation and scientific discussions with other researchers</gtr:impact><gtr:outcomeId>58c6eb8fdd9e40.13802462</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talks with patient group</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2164A210-56B6-4D16-A2A2-8E326A4B3620</gtr:id><gtr:impact>Patients attending Glaucoma clinic at Moorefield's Eye Hospital were informed of current and prospective therapies available for their treatment.

Have received emails from patients asking further questions.</gtr:impact><gtr:outcomeId>5464be1ae7da88.56702964</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient symposium- Moorfields Eye Hospital</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>50FD4CB9-77FF-449B-AEA2-7B059DB13649</gtr:id><gtr:impact>Patient- Clinical discussions to understand impact of eye disease</gtr:impact><gtr:outcomeId>56d8713f5fdeb6.53606359</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invitation to speak at retina conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>18324136-BE46-42F7-99B3-2A072B35DC9F</gtr:id><gtr:impact>I was invited to give a talk at a symposium organized by the German Foundation PRO RETINA. The meeting was attended by circa 400 Scientists, Young Research Fellows and Eye Charity members</gtr:impact><gtr:outcomeId>58c80a9c424962.66581868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem cell conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C02EC42C-23D5-4E15-8062-E642FE10B7CE</gtr:id><gtr:impact>Discussions with Scientists an Clinicians on new developments on the application of stem cells to therapies.</gtr:impact><gtr:outcomeId>58c6e97b96acd6.99585785</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature on visual disability</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0DCFD248-FD5E-4370-85FD-5B06E2DCAD6E</gtr:id><gtr:impact>People becoming more aware of visual disability and prospects for future therapies

Have received emails from the public for information on my work</gtr:impact><gtr:outcomeId>5464bd3fb380a2.99802583</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARVO meeting 2015a (USA)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>001F08AD-5009-4E70-B6A6-0B96BA5B3670</gtr:id><gtr:impact>Poster presentation and scientific discussions with other researchers</gtr:impact><gtr:outcomeId>56d86c71a77473.00490066</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dresden Conference 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>43FF228B-4521-453C-84A5-502143965182</gtr:id><gtr:impact>Poster presentation- Generated interesting discussion in the stem cell field</gtr:impact><gtr:outcomeId>56d8705f893341.49565935</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARVO meeting 2015b (USA)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>42985847-28FF-4034-AC53-B1EA0C89742D</gtr:id><gtr:impact>Poster presentation and scientific discussions with other researchers</gtr:impact><gtr:outcomeId>56d86d72687246.32585464</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>210000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Santen Pharmaceutical Co., Ltd</gtr:fundingOrg><gtr:id>7F6F49F4-608B-490C-980F-EC357E304D78</gtr:id><gtr:outcomeId>56d880461e2ca4.33409893</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Moorfields Eye Charity</gtr:fundingOrg><gtr:id>8FD255A0-3707-4C92-8021-658B79070F7F</gtr:id><gtr:outcomeId>56d87f1b3b6f45.89988176</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>69704</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>The Special Trustees of Moorfields Eye Hospital General Fund</gtr:department><gtr:description>Project grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Moorfields Eye Hospital NHS Foundation Trust</gtr:fundingOrg><gtr:id>4CFA510B-94B9-46DD-8939-87DE0BBB80E8</gtr:id><gtr:outcomeId>545a530f681758.73151163</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BIRAX</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F2D44678-1926-4556-8EC8-43545DF95923</gtr:id><gtr:outcomeId>545a6e4632ba79.90777434</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1AA9D2B3-47D2-4A98-BA25-177736389B15</gtr:id><gtr:title>Downregulation of the Canonical WNT Signaling Pathway by TGF?1 Inhibits Photoreceptor Differentiation of Adult Human M&amp;uuml;ller Glia with Stem Cell Characteristics.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23150a0495cb7176876c64421c56cb97"><gtr:id>23150a0495cb7176876c64421c56cb97</gtr:id><gtr:otherNames>Angbohang A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>56d8879b0c2602.71659593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E632A29-7DDC-46E3-9FCE-4DFA77FD2450</gtr:id><gtr:title>M&amp;uuml;ller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14ba24773ec7260ebbe3dbf11dbbd4c5"><gtr:id>14ba24773ec7260ebbe3dbf11dbbd4c5</gtr:id><gtr:otherNames>Eastlake K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>56d88766afcef2.18728695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFC5F4BF-34CD-472B-AD93-6D9E5510F37D</gtr:id><gtr:title>Effects of light on retinal pigment epithelial cells, neurosensory retinal cells and M&amp;uuml;ller cells treated with Brilliant Blue G.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; experimental ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2145ad63224295d03786f1398221ae00"><gtr:id>2145ad63224295d03786f1398221ae00</gtr:id><gtr:otherNames>Mansoor S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1442-6404</gtr:issn><gtr:outcomeId>56d9c75b810aa6.19920027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>237695BC-73D3-48C0-A329-7375625DD197</gtr:id><gtr:title>Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal M&amp;uuml;ller Cells.</gtr:title><gtr:parentPublicationTitle>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a3371fac5d9ea2b87c93bb739232df6"><gtr:id>2a3371fac5d9ea2b87c93bb739232df6</gtr:id><gtr:otherNames>Ram?rez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1080-7683</gtr:issn><gtr:outcomeId>56d9c75b3ab6c3.13347851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEB84C9D-02B0-428C-8500-CC49689F8BE7</gtr:id><gtr:title>IL-1? induces IL-6 production in retinal M&amp;uuml;ller cells predominantly through the activation of p38 MAPK/NF-?B signaling pathway.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>545a4347932fd4.22400607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F25E7A1-54C8-4E55-844B-BD5A2C701143</gtr:id><gtr:title>Amyloid ? Peptide Induces Apoptosis Through P2X7 Cell Death Receptor in Retinal Cells: Modulation by Marine Omega-3 Fatty Acid DHA and EPA.</gtr:title><gtr:parentPublicationTitle>Applied biochemistry and biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de5d66a3d5607d8554b83a79ffb27df2"><gtr:id>de5d66a3d5607d8554b83a79ffb27df2</gtr:id><gtr:otherNames>Wakx A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0273-2289</gtr:issn><gtr:outcomeId>56d9c75b5ad248.91400659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B8D4BAD-59E3-45B7-B0AC-31AC8970FB4F</gtr:id><gtr:title>Genetic background and light-dependent progression of photoreceptor cell degeneration in Prominin-1 knockout mice.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6567f1d9c8cca47cc277c9fe31c616f"><gtr:id>f6567f1d9c8cca47cc277c9fe31c616f</gtr:id><gtr:otherNames>Dellett M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>doi_55f9859850c2c1f6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F4C328B-A190-45E1-81CE-232C8010607D</gtr:id><gtr:title>Optimized feline vitrectomy technique for therapeutic stem cell delivery to the inner retina.</gtr:title><gtr:parentPublicationTitle>Veterinary ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/716052a62dfef85081d6931c3a4bb50b"><gtr:id>716052a62dfef85081d6931c3a4bb50b</gtr:id><gtr:otherNames>Jayaram H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1463-5216</gtr:issn><gtr:outcomeId>545a4347e89563.06033415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0469B045-9395-4911-8CCE-49E4A38F7341</gtr:id><gtr:title>IL-1? Upregulates IL-8 Production in Human M&amp;uuml;ller Cells Through Activation of the p38 MAPK and ERK1/2 Signaling Pathways.</gtr:title><gtr:parentPublicationTitle>Inflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0360-3997</gtr:issn><gtr:outcomeId>545a4347bd3ff9.13399099</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K008722/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>